In a cohort of BNT162b2 (Pfizer–BioNTech) mRNA vaccine recipients (n = 1,090), we observed
that spike-specific IgG antibody levels and ACE2 antibody binding inhibition responses …

BACKGROUND Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused
more than 1 million deaths worldwide; thus, there is an urgent need to develop preventive …

Background: The effects of immunosuppression on responses to SARS-CoV-2 vaccine are
unclear given that patients receiving immune-modifying therapies, who constitute 2.8% of …

Background Pronounced sex differences in the susceptibility and response to SARS-CoV-2
infection remain poorly understood. Emerging evidence has highlighted the potential …

Importance Some individuals who were infected by the SARS-CoV-2 Omicron variant may
have been completely unaware of their infectious status while the virus was actively …

Long-term studies of immunogenicity of SARS-CoV-2 vaccines in patients with cancer are
needed to inform evidence-based guidelines for booster vaccinations and to tailor sequence …

Lay Summary T-cell and antibody responses to severe acute respiratory syndrome
coronavirus 2 vaccination in inflammatory bowel disease patients are poorly correlated. T-cell …

Sample preparation for protein quantification by mass spectrometry requires multiple
processing steps including denaturation, reduction, alkylation, protease digestion, and peptide …

(COVID-19) prevention in the United States. These include the messenger RNA (mRNA)
platform vaccines (mRNA-1273; Moderna/National Institutes of Health) and BNT162b2 (Pfizer-…

Objectives In the United States, minimum standards for quality control (QC) are specified in
federal law under the Clinical Laboratory Improvement Amendment and its revisions. Beyond …